Zobrazeno 1 - 10
of 145
pro vyhledávání: '"adjuvanted influenza vaccine"'
Autor:
Alexander Domnich, Giancarlo Icardi, Donatella Panatto, Marianna Scarpaleggia, Carlo-Simone Trombetta, Matilde Ogliastro, Federica Stefanelli, Bianca Bruzzone, Andrea Orsi
Publikováno v:
International Journal of Infectious Diseases, Vol 147, Iss , Pp 107202- (2024)
ABSTRACT: Objectives: In order to support policymakers in allocating resources, we aimed to assess vaccine effectiveness (VE) of inactivated influenza vaccines (IIVs) available for Italian adults in the 2023/2024 season. Methods: A hospital-based tes
Externí odkaz:
https://doaj.org/article/5368a0f73dd448c8b156157cc0a7c644
Autor:
Ian McGovern, Benjamin Chastek, Tim Bancroft, Noah Webb, Mahrukh Imran, Stephen I. Pelton, Mendel D.M. Haag
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107160- (2024)
Objectives: This study evaluated relative vaccine effectiveness (rVE) of MF59-adjuvanted trivalent inactivated influenza vaccine (aTIV) vs high-dose trivalent inactivated influenza vaccine (HD-TIV) for prevention of test-confirmed influenza emergency
Externí odkaz:
https://doaj.org/article/ba74f04987d645e59bb10f9679ce77ec
Autor:
Kenneth E. Schmader, Christine K. Liu, Brendan Flannery, Wes Rountree, Heidi Auerbach, Elizabeth D. Barnett, Elizabeth P. Schlaudecker, Christopher A. Todd, Marek Poniewierski, Mary A. Staat, Theresa Harrington, Rongxia Li, Karen R. Broder, Emmanuel B. Walter
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-11 (2023)
Abstract Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated influenza vaccine (HD-IIV) are U.S.-licensed for adults aged ≥ 65 years. This study compared serum hemagglutination inhibition (HAI) antibody titers for t
Externí odkaz:
https://doaj.org/article/275af69609234cc6b4651fc11dd8d745
Autor:
Alexander Domnich, Donatella Panatto, Elena Pariani, Christian Napoli, Maria Chironna, Ilaria Manini, Caterina Rizzo, Andrea Orsi, Giancarlo Icardi
Publikováno v:
International Journal of Infectious Diseases, Vol 125, Iss , Pp 164-169 (2022)
ABSTRACT: Objectives: In this study, we aimed to investigate the relative vaccine effectiveness (rVE) of the MF59-adjuvanted trivalent (aTIV) and non-adjuvanted quadrivalent (QIVe) egg-based standard-dose vaccines against severe laboratory-confirmed
Externí odkaz:
https://doaj.org/article/d59f1e22c44344a683bb1fe4c54d3775
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Infectious Medicine, Vol 1, Iss 3, Pp 163-170 (2022)
Background: Young children are at high risk for developing complications of influenza, as well as severe clinical presentation of disease. Vaccination provides direct protection and reduces symptom severity in breakthrough infections. We assessed whe
Externí odkaz:
https://doaj.org/article/783bc517147f43d79d3dfec0fae39506
Autor:
Alexander Domnich, Chiara de Waure
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 855-863 (2022)
ABSTRACT: Objectives: MF59-adjuvanted standard-dose and nonadjuvanted high-dose seasonal influenza vaccines have been developed to protect the elderly at high risk of severe complications. This study aimed to summarize the available evidence on the c
Externí odkaz:
https://doaj.org/article/14d28614ca6243eba72987fd9dc49387
Autor:
Luca Pestarino, Alexander Domnich, Andrea Orsi, Federico Bianchi, Elisa Cannavino, Pier Claudio Brasesco, Gianluca Russo, Simone Valbonesi, Giacomo Vallini, Matilde Ogliastro, Giancarlo Icardi
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1748 (2023)
In Italy, several types of seasonal influenza vaccines (SIVs) are available for older adults, but for the 2022/2023 season there were no guidelines on their specific use. This cross-sectional study assessed the frequency and determinants of the use o
Externí odkaz:
https://doaj.org/article/1ba270094b874187a59038becb243e3b
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5514-5521 (2021)
Older adults are at disproportionately high risk of severe influenza-related outcomes and represent the main target of the annual influenza vaccination. The protective effect of seasonal influenza vaccination on the observed mortality indicators is c
Externí odkaz:
https://doaj.org/article/d136b8a7170c49c79d9700e5cf36e034
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.